These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


184 related items for PubMed ID: 1902758

  • 21. Antitumor activity of 1-alkoxycarbonylalkylcarbamoyl-5-fluorouracil derivatives by oral administration.
    Iigo M, Hoshi A, Inomata M, Ando N, Kuretani K.
    J Pharmacobiodyn; 1981 Mar; 4(3):203-10. PubMed ID: 7252769
    [Abstract] [Full Text] [Related]

  • 22. Antitumor activity in the culture supernatant fluid of Fusobacterium nucleatum strain KO-31.
    Tamai K, Nakao J, Nakagawa K, Watanabe K, Sakashita H, Nishiwaki Y, Nakashin T.
    Jpn J Exp Med; 1983 Oct; 53(5):251-6. PubMed ID: 6433084
    [Abstract] [Full Text] [Related]

  • 23. Adverse effect of antitumor drugs on the prevention of metastasis in mice.
    Hasegawa Y, Irikura T, Mizuno D.
    Chem Pharm Bull (Tokyo); 1970 Nov; 18(11):2348-50. PubMed ID: 5494856
    [No Abstract] [Full Text] [Related]

  • 24. Chemotherapy studies in an animal tumor spectrum. II. Sensitivity of tumors to fourteen antitumor chemicals.
    Tarnowski GS, Schmid FA, Cappuccino JG, Stock CC.
    Cancer Res; 1966 Mar; 26(3 Pt 2):181-206. PubMed ID: 4223040
    [No Abstract] [Full Text] [Related]

  • 25. [Effect of combination chemotherapy of nitrosourea MCNU with various anti-tumor agents].
    Ninomiya K, Sekido S, Araki T.
    Gan To Kagaku Ryoho; 1984 Jun; 11(6):1315-23. PubMed ID: 6428326
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Role of hypoxia in anticancer drug-induced cytotoxicity for Ehrlich ascites cells.
    Gupta V, Costanzi JJ.
    Cancer Res; 1987 May 01; 47(9):2407-12. PubMed ID: 2436764
    [Abstract] [Full Text] [Related]

  • 31. IN VITRO TEST SYSTEMS FOR CANCER CHEMOTHERAPY. II. CORRELATION OF IN VITRO INHIBITION OF DEHYDROGENASE AND GROWTH WITH IN VIVO INHIBITION OF EHRLICH ASCITES TUMOR.
    DIPAOLO JA.
    Proc Soc Exp Biol Med; 1963 Nov 01; 114():384-7. PubMed ID: 14101198
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Radiochemotherapeutic treatment of bronchial cancer: comparative study of 2 attempts].
    Huys J, Van Vaerenbergh PM, Goetghebuer T, De Boesinghe Lde T.
    J Belge Radiol; 1972 Nov 01; 55(4):463-6. PubMed ID: 4639428
    [No Abstract] [Full Text] [Related]

  • 35. Cross resistance between vinca alkaloids and anthracyclines in Ehrlich ascites tumor in vivo.
    Dano K.
    Cancer Chemother Rep; 1972 Dec 01; 56(6):701-8. PubMed ID: 4660629
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Systemic therapy of bladder cancer.
    Salem PA.
    Prog Clin Biol Res; 1984 Dec 01; 162B():95-105. PubMed ID: 6209726
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.